This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2013 Jan;10(1):5-6.

doi: 10.1038/nrurol.2012.219. Epub 2012 Nov 20.

Bladder cancer: Lack of progress in bladder cancer--what are the obstacles?

Mark S Soloway¹

Affiliations

PMID: 23165404
DOI: 10.1038/nrurol.2012.219

Bladder cancer: Lack of progress in bladder cancer--what are the obstacles?

Mark S Soloway. Nat Rev Urol. 2013 Jan.

. 2013 Jan;10(1):5-6.

doi: 10.1038/nrurol.2012.219. Epub 2012 Nov 20.

Author

Mark S Soloway¹

Affiliation

¹ Department of Urology, University of Miami Miller School of Medicine, PO Box 016960 (M814), Miami, FL 33103, USA. msoloway@med.miami.edu

PMID: 23165404
DOI: 10.1038/nrurol.2012.219

No abstract available

PubMed Disclaimer

Similar articles

Bladder cancer in 2016: News in diagnosis, treatment, and risk group assessment.
Zigeuner R. Zigeuner R. Nat Rev Urol. 2017 Feb;14(2):74-76. doi: 10.1038/nrurol.2016.264. Epub 2017 Jan 4. Nat Rev Urol. 2017. PMID: 28050015 Review. No abstract available.
Bladder cancer in 2012: Challenging current paradigms.
Noon AP, Catto JW. Noon AP, et al. Nat Rev Urol. 2013 Feb;10(2):67-8. doi: 10.1038/nrurol.2012.252. Epub 2013 Jan 8. Nat Rev Urol. 2013. PMID: 23295237 Review. No abstract available.
Bladder cancer: revealing news about a hidden threat.
Campbell BD. Campbell BD. Nursing. 2006 Apr;36(4):54-7. doi: 10.1097/00152193-200604000-00041. Nursing. 2006. PMID: 16582750 No abstract available.
Pioglitazone and bladder cancer: FDA's assessment.
Hampp C, Pippins J. Hampp C, et al. Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):117-118. doi: 10.1002/pds.4154. Epub 2017 Jan 9. Pharmacoepidemiol Drug Saf. 2017. PMID: 28067434 Review. No abstract available.
Are we making significant progress in the diagnosis and management of bladder cancer?
DeCastro GJ, Steinberg GD. DeCastro GJ, et al. J Urol. 2010 May;183(5):1667-8. doi: 10.1016/j.juro.2010.02.2376. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299061 No abstract available.

See all similar articles

Cited by

JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer.
Pan CW, Liu H, Zhao Y, Qian C, Wang L, Qi J. Pan CW, et al. Oncotarget. 2016 Jun 7;7(23):35119-31. doi: 10.18632/oncotarget.9046. Oncotarget. 2016. PMID: 27147566 Free PMC article.
Small nucleolar RNAs signature (SNORS) identified clinical outcome and prognosis of bladder cancer (BLCA).
Cao R, Ma B, Yuan L, Wang G, Tian Y. Cao R, et al. Cancer Cell Int. 2020 Jul 10;20:299. doi: 10.1186/s12935-020-01393-7. eCollection 2020. Cancer Cell Int. 2020. PMID: 32669975 Free PMC article.
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenografts.
Wei L, Chintala S, Ciamporcero E, Ramakrishnan S, Elbanna M, Wang J, Hu Q, Glenn ST, Murakami M, Liu L, Gomez EC, Sun Y, Conroy J, Miles KM, Malathi K, Ramaiah S, Anbarasu A, Woloszynska-Read A, Johnson CS, Conroy J, Liu S, Morrison CD, Pili R. Wei L, et al. Oncotarget. 2016 Nov 22;7(47):76374-76389. doi: 10.18632/oncotarget.13062. Oncotarget. 2016. PMID: 27823983 Free PMC article.
Prognostic significance of BZW2 expression in lung adenocarcinoma patients.
Wang S, Bai W, Huang J, Lv F, Bai H. Wang S, et al. Int J Clin Exp Pathol. 2019 Dec 1;12(12):4289-4296. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933829 Free PMC article.
Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis.
Kang W, Wang Q, Dai Y, Wang H, Wang M, Wang J, Zhang D, Sun P, Qi T, Jin X, Cui Z. Kang W, et al. Cell Death Dis. 2020 Dec 7;11(12):1038. doi: 10.1038/s41419-020-03240-z. Cell Death Dis. 2020. PMID: 33288752 Free PMC article.

See all "Cited by" articles

References

1. BJU Int. 2001 Nov;88(7):683-5 - PubMed
1. Cancer. 2009 Sep 15;115(18):4096-103 - PubMed
1. J Urol. 1983 Dec;130(6):1083-6 - PubMed
1. BJU Int. 2013 Mar;111(3):419-26 - PubMed
1. Eur Urol. 2008 Aug;54(2):303-14 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information